Table 1 Patient’s characteristics at baseline (n=20)
Age (years)–mean (range) | 69 | (54–84) |
|---|---|---|
Initial treatment, n (%) | ||
Curative intention | 9 | (45) |
Primary ADT | 11 | (55) |
ADT method, n (%) | ||
Bilateral orchiectomy | 9 | (45) |
LHRH agonists | 11 | (55) |
Second-line treatment, n (%) | ||
Oestrogens | 15 | (75) |
Ketoconazol plus prednisone | 1 | (5) |
Chemotherapy | 1 | (5) |
Duration of ADT, months (range) | 24,5 | (6–81) |
Metastases, n (%) | ||
Bone | 14 | (70) |
Lymph node | 14 | (70) |
Visceral | 0 | (0) |
None | 6 | (30) |
Progression, n (%) | ||
Biochemical | 13 | (65) |
Metastases | 7 | (35) |
Patients that completed treatment protocol, n (%) | 14 | (70) |
